Mayne Pharma Intl Drug Patent Portfolio
Mayne Pharma Intl's Family Patents
Recently granted tentative Approvals to Mayne Pharma Intl
These tentative approvals reflect continued regulatory progress across both innovative and generic submissions related to Mayne Pharma Intl's portfolio.
Generic tentative approvals
| Drug Name | Active Ingredient | Submission Type | Submission Category | Submission Date |
|---|---|---|---|---|
| Ethinyl Estradiol; Levonorgestrel | Ethinyl Estradiol; Levonorgestrel |
ORIG-1
ⓘ
Orig = Original submission Suppl = Supplement submission Number = submission sequence | (Not Available) | 28 Apr, 2017 |
Explore deeper patents analysis
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List